Clinical Trial Update: Product Transference Study of Testagen™ TDS®-Testosterone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Testagen TDS transdermal testosterone evaluating product transference. The study targets hypogonadotropic hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Testagen TDS (testosterone)

Snippet

Sponsor: Transdermal Delivery Solutions Corp | Conditions: Hypogonadotropism | Phase 2 | Status: UNKNOWN